Literature DB >> 30789198

The MIG Chemokine in Inflammatory Myopathies.

S R Paparo1.   

Abstract

The chemokine monokine induced by interferon (IFN)-γ (MIG) is expressed in idiopathic inflammatory myopathies muscle. Abundant expression of MIG was observed on macrophages and T cells surrounding and invading non-necrotic muscle fibers in polymyositis and in inclusion-body myositis and in T cells in perimysial infiltrates of dermatomyositis. MIG is also localized to blood vessel endothelial cells in all inflammatory and normal muscle tissues and it exerts its biological effects mainly via binding to the chemokine (C-X-C motif) receptor (CXCR)3. Serum MIG is high in patients with inflammatory myopathies. Human skeletal muscle cells might actively self-promote muscular inflammation by eliciting MIG secretion, under the influence of cytokines (IFN-γ, tumor necrosis factor-α), which can amplify Th1 cell tissue infiltration in vivo. It has been shown that drugs able to block the MIG/CXCR3 axis can suppress inflammation in muscle.

Entities:  

Keywords:  CXCR3; Dermatomyositis; Inflammatory Myopathies; MIG

Mesh:

Substances:

Year:  2019        PMID: 30789198     DOI: 10.7417/CT.2019.2108

Source DB:  PubMed          Journal:  Clin Ter        ISSN: 0009-9074


  2 in total

1.  Mixed T Helper1/T Helper2/T Cytotoxic Profile in Subjects with Chronic Chagas Disease with Hypersensitivity Reactions to Benznidazole.

Authors:  Melisa D Castro Eiro; María A Natale; Carlos A Vigliano; Susana A Laucella; María G Alvarez; Araceli Castro; Débora Seigelshifer; Rodolfo Viotti; Marisa Fernández; Luis Mazzuoccolo; Bruno Lococo; Graciela L Bertocchi; Gonzalo Cesar; María C Albareda; María J Elias; María B Caputo; Eduardo Gaddi; Jeanette Balbaryski
Journal:  Microbiol Spectr       Date:  2022-08-08

2.  Molecular evidence suggesting the persistence of residual SARS-CoV-2 and immune responses in the placentas of pregnant patients recovered from COVID-19.

Authors:  Hao Wu; Shujie Liao; Yiming Wang; Ming Guo; Xingguang Lin; Jianli Wu; Renjie Wang; Dan Lv; Di Wu; Mengzhou He; Bai Hu; Rui Long; Jing Peng; Hui Yang; Heng Yin; Xin Wang; Zhixiang Huang; Ke Lan; Yanbin Zhou; Wei Zhang; Zhenyu Xiao; Yun Zhao; Dongrui Deng; Hongmei Wang
Journal:  Cell Prolif       Date:  2021-07-22       Impact factor: 8.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.